Pfizer's Norvasc
Executive Summary
Once-daily calcium channel blocker amlodipine will be subject of FDA Cardiovascular and Renal Drugs Advisory Committee June 7. Lederle's Monocor (bisoprolol) and Marion Merrell Dow's intravenous Cardizem (diltiazem) will be discussed June 6. Both days' meetings will be held at NIH's Jack Masur Auditorium from 9 am to 5 pm.